Scientists call for EU embryo research and development consensus
This article was originally published in Clinica
Executive Summary
Leading EU scientists have called on member states to remove political and legislative barriers to stem cell research, in the belief that differences in policy "seriously hinder [its] advancement", particularly with regard to international collaboration and sharing biomedical knowledge. Despite the common funding provided for this under the European Commission's FP-6 and FP-7 research frameworks, "scientists within Europe cannot freely exchange personnel and cell lines", said ESTOOLS consortium co-ordinator Professor Peter Andrews.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.